Clinical Presentation of COVID-19 and Antibody Responses in Bangladeshi Patients Infected with the Delta or Omicron Variants of SARS-CoV-2
暂无分享,去创建一个
A. Ghosh | O. Landt | A. Islam | R. Mamunur | M. Kaiser | M. A. Molla | Tasnim Nafisa | M. Yeasmin | R. H. Ratul | M. Sharif | N. Hosen | M. Amin | S. Lytton | Md Rakibul Hassan Bulbul | Mymuna Binte Mosaddeque | Shahjahan Siddike Shakil | Md. Rakibul Hassan Bulbul
[1] D. Barouch. Covid-19 Vaccines — Immunity, Variants, Boosters , 2022, The New England journal of medicine.
[2] A. Islam,et al. Transmission Dynamics and Genomic Epidemiology of Emerging Variants of SARS-CoV-2 in Bangladesh , 2022, Tropical medicine and infectious disease.
[3] A. Galvani,et al. The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2 , 2022, Proceedings of the National Academy of Sciences of the United States of America.
[4] M. Kalam,et al. Transmission Pathways and Genomic Epidemiology of Emerging Variants of SARS-CoV-2 in the Environment , 2022, COVID.
[5] E. Lam,et al. Detection of SARS-CoV-2 VOC-Omicron using commercial sample-to-answer real-time RT-PCR platforms and melting curve-based SNP assays , 2022, Journal of Clinical Virology Plus.
[6] K. Ferreira-Paim,et al. Clinical-Epidemiology Aspect of Inpatients With Moderate or Severe COVID-19 in a Brazilian Macroregion: Disease and Countermeasures , 2022, Frontiers in Cellular and Infection Microbiology.
[7] C. Alves,et al. Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants , 2022, Scientific Reports.
[8] Naveen Dhawan,et al. Characteristics of COVID-19 Breakthrough Infections among Vaccinated Individuals and Associated Risk Factors: A Systematic Review , 2022, Tropical medicine and infectious disease.
[9] S. A. Abdool Karim,et al. Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study , 2022, The Lancet Global Health.
[10] Asma Al Balushi,et al. COVID-19-Associated Mucormycosis: An Opportunistic Fungal Infection. A Case Series and Review , 2022, International Journal of Infectious Diseases.
[11] E. Klein,et al. The displacement of the SARS-CoV-2 variant Delta with Omicron: An investigation of hospital admissions and upper respiratory viral loads , 2022, eBioMedicine.
[12] H. Jinno,et al. Discrimination of SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 Using a High-Resolution Melting-Based Assay: a Pilot Study , 2022, bioRxiv.
[13] H. Ullum,et al. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study , 2022, The Lancet Infectious Diseases.
[14] C. Steves,et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study , 2022, The Lancet.
[15] J. L. Bernal,et al. COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England , 2022, The Lancet Infectious Diseases.
[16] Nicholas R. Thompson,et al. Genome Sequences of 25 SARS-CoV-2 Sublineage B.1.1.529 Omicron Strains in Bangladesh , 2022, Microbiology Resource Announcements.
[17] L. Madoff,et al. Characterization of immune responses in fully vaccinated individuals following breakthrough infection with the SARS-CoV-2 delta variant , 2022, Science Translational Medicine.
[18] Md. Rabiul Islam. The SARS‐CoV‐2 Omicron (B.1.1.529) variant and the re‐emergence of COVID‐19 in Europe: An alarm for Bangladesh , 2022, Health science reports.
[19] F. Kirchhoff,et al. Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning? , 2022, Journal of virology.
[20] R. Poduri,et al. Omicron, a new SARS-CoV-2 variant: assessing the impact on severity and vaccines efficacy , 2022, Human Vaccines & Immunotherapeutics.
[21] Md. Rabiul Islam,et al. New Coronavirus Variants are Creating More Challenges to Global Healthcare System: A Brief Report on the Current Knowledge , 2022, Clinical pathology.
[22] A. Walls,et al. Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement , 2021, bioRxiv.
[23] M. Bhuiyan,et al. Detection of highly muted coronavirus variant Omicron (B.1.1.529) is triggering the alarm for South Asian countries: Associated risk factors and preventive actions , 2021, Journal of medical virology.
[24] Y. Liu,et al. The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern , 2021, Frontiers in Public Health.
[25] A. Ghosh,et al. Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021 , 2021, Viruses.
[26] Jahida Gulshan,et al. Systematic Assessment of COVID-19 Pandemic in Bangladesh: Effectiveness of Preparedness in the First Wave , 2021, Frontiers in Public Health.
[27] G. Wiesmüller,et al. Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination , 2021, Journal of Infection.
[28] K. Jöckel,et al. The performance of the SARS-CoV-2 RT-PCR test as a tool for detecting SARS-CoV-2 infection in the population , 2021, Journal of Infection.
[29] S. Antinori,et al. COVID-19–Associated Pulmonary Aspergillosis, March–August 2020 , 2021, Emerging infectious diseases.
[30] K. Crandall,et al. Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity , 2020, Scientific Reports.
[31] M. Hallek,et al. COVID‐19 associated pulmonary aspergillosis , 2020, Mycoses.